CA
NZ
UK
AU
IND
US
…
AdvanSix Inc., integrated chemistry company, engages in the manufacture and sale of polymer resins in the United States and internationally. The company offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. It also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and resins. In addition, the company offers intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines; and cyclohexanol, sulfuric acid, ammonia, and carbon dioxide, as well as automotive components, water treatment, and pharmaceutical intermediates. It offers its products under the Aegis, Sulf-N, Nadone, Naxol, and EZ-Blox under brand names. The company sells its products directly and through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
Source: TradingView
The charts and visual representations are sourced from TradingView through embedded widgets. For any issues with chart display, please visit the TradingView website
A unique technical analysis driven score developed by Kalkine showing momentum in stock prices based on select technical indicators identified.
AdvanSix Inc is a U.S.-based chemical manufacturer of nylon 6 intermediates and ammonium sulfate fertilizer serving automotive, industrial and agricultural markets. Long-term growth may be supported by demand for nylon 6 in lightweighting, reshoring of domestic chemical supply chains and steady fertilizer needs, and the company's integrated manufacturing may help control costs and reliability.
Material risks include commodity feedstock and energy price volatility, cyclicality of end markets such as automotive and textiles, environmental and regulatory exposure, and operational execution risk at key plants.
Note: The summary and risk score provided above is created by AI and should not be construed as a recommendation of Kalkine.
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Income before tax | 54.43M | 45.58M | 69.22M | 225.79M | 185.12M |
| Net income | 49.29M | 44.15M | 54.62M | 171.89M | 139.79M |
| Selling general administrative | 104.75M | 94.02M | 95.54M | 87.75M | 82.98M |
| Gross profit | 173.64M | 152.94M | 165.09M | 314.48M | 274.12M |
| Reconciled depreciation | 79.74M | 76.18M | 73.01M | 69.35M | 65.34M |
| Ebit | 62.91M | 56.89M | 76.71M | 228.57M | 190.14M |
| Ebitda | 142.65M | 133.06M | 149.72M | 297.93M | 255.48M |
| Depreciation and amortization | 79.74M | 76.18M | 73.01M | 69.35M | 65.34M |
| Non operating income net other | - | - | - | 1.84M | -1.00M |
| Operating income | 67.52M | 58.91M | 69.55M | 228.57M | 190.14M |
| Other operating expenses | 1454.72M | 1458.64M | 1464.05M | 1718.91M | 1493.49M |
| Interest expense | 8.48M | 11.31M | 7.49M | 2.78M | 5.02M |
| Tax provision | 5.14M | 1.43M | 14.60M | 53.91M | 45.33M |
| Net interest income | -8.48M | -11.31M | -7.49M | -2.78M | -5.02M |
| Income tax expense | 5.14M | 1.43M | 14.60M | 53.91M | 45.33M |
| Total revenue | 1522.23M | 1517.56M | 1533.60M | 1945.64M | 1684.62M |
| Total operating expenses | 106.12M | 94.02M | 95.54M | 87.75M | 82.98M |
| Cost of revenue | 1348.59M | 1364.62M | 1368.51M | 1631.16M | 1410.50M |
| Total other income expense net | -13.08M | -13.34M | -0.33M | -2.78M | -5.02M |
| Net income from continuing ops | 49.29M | 44.15M | 54.62M | 171.89M | 139.79M |
| Net income applicable to common shares | - | - | - | 171.89M | 139.79M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Total assets | 1706.15M | 1594.92M | 1496.02M | 1495.33M | 1312.00M |
| Intangible assets | 40.09M | 43.14M | 46.19M | 49.24M | - |
| Other current assets | 8.64M | 8.99M | 11.38M | 9.24M | 6.10M |
| Total liab | 890.93M | 820.27M | 756.78M | 757.15M | 710.81M |
| Total stockholder equity | 815.22M | 774.65M | 739.24M | 738.18M | 601.19M |
| Deferred long term liab | - | - | - | 160.41M | 133.33M |
| Other current liab | 45.00M | 47.26M | 44.88M | 48.82M | 49.71M |
| Common stock | 0.33M | 0.33M | 0.33M | 0.32M | 0.32M |
| Capital stock | 0.33M | 0.33M | 0.33M | 0.32M | 0.32M |
| Retained earnings | 663.02M | 631.54M | 605.07M | 567.52M | 411.52M |
| Other liab | - | - | - | 170.10M | 165.41M |
| Good will | 56.19M | 56.19M | 56.19M | 56.19M | 17.59M |
| Other assets | - | - | - | 23.22M | 40.38M |
| Cash | 19.77M | 19.56M | 29.77M | 30.98M | 15.10M |
| Total current liabilities | 389.95M | 357.10M | 358.92M | 393.49M | 309.82M |
| Current deferred revenue | 14.54M | 37.54M | 15.68M | 34.43M | 2.75M |
| Net debt | 362.93M | 329.33M | 236.25M | 199.06M | 256.61M |
| Short term debt | 45.30M | 42.49M | 32.05M | 37.47M | 36.13M |
| Short long term debt total | 382.69M | 348.89M | 266.01M | 230.04M | 271.71M |
| Other stockholder equity | 142.87M | 136.81M | 137.99M | 174.54M | 195.90M |
| Property plant equipment | - | - | - | 925.75M | 904.17M |
| Total current assets | 440.61M | 387.12M | 419.80M | 440.93M | 349.85M |
| Net tangible assets | - | - | - | 632.75M | 583.60M |
| Net receivables | 175.71M | 146.18M | 166.83M | 185.20M | 179.09M |
| Long term debt | 215.00M | 195.00M | 170.00M | 115.00M | 135.00M |
| Inventory | 236.50M | 212.39M | 211.83M | 215.50M | 149.57M |
| Accounts payable | 284.02M | 228.76M | 258.27M | 272.77M | 221.23M |
| Accumulated other comprehensive income | 9.00M | 5.97M | -4.14M | -4.20M | -6.54M |
| Common stock total equity | - | - | - | 0.32M | 0.32M |
| Retained earnings total equity | - | - | - | 567.52M | 411.52M |
| Treasury stock | - | - | - | -0.04M | -0.04M |
| Non currrent assets other | 41.04M | 37.17M | 25.38M | -137.19M | 40.38M |
| Non current assets total | 1265.54M | 1207.80M | 1076.22M | 1054.40M | 962.14M |
| Capital lease obligations | 165.56M | 153.89M | 96.01M | 115.04M | 136.71M |
| Long term debt total | - | - | - | 115.00M | 135.00M |
| Breakdown | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
|---|---|---|---|---|---|
| Type | yearly | yearly | yearly | yearly | yearly |
| Date | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 |
| Investments | - | -142.90M | -100.65M | -189.27M | -67.56M |
| Change to liabilities | - | - | - | 43.05M | 40.05M |
| Total cashflows from investing activities | -122.61M | -142.90M | -110.90M | -189.27M | -67.56M |
| Net borrowings | 19.00M | 23.99M | 54.06M | -20.00M | -140.00M |
| Total cash from financing activities | -0.05M | -2.71M | -7.87M | -68.44M | -146.79M |
| Change to operating activities | - | - | - | -26.11M | 4.77M |
| Net income | 49.29M | 44.15M | 54.62M | 171.89M | 139.79M |
| Change in cash | 0.20M | -10.20M | -1.22M | 15.88M | 4.49M |
| Begin period cash flow | 19.56M | 29.77M | 30.98M | 15.10M | 10.61M |
| End period cash flow | 19.77M | 19.56M | 29.77M | 30.98M | 15.10M |
| Total cash from operating activities | 122.86M | 135.41M | 117.55M | 273.60M | 218.85M |
| Issuance of capital stock | 0.27M | 0.86M | 1.13M | 1.30M | 0.55M |
| Depreciation | 79.74M | 76.18M | 73.01M | 69.35M | 65.34M |
| Other cashflows from investing activities | -122.61M | -9.18M | -3.52M | -99.82M | -10.75M |
| Dividends paid | 17.18M | 17.14M | 16.66M | -15.07M | -3.52M |
| Change to inventory | -24.11M | -0.56M | 3.29M | -57.04M | 31.23M |
| Change to account receivables | -29.50M | 19.34M | 29.83M | 17.84M | -53.77M |
| Sale purchase of stock | -1.66M | -10.43M | -46.15M | -33.75M | -0.65M |
| Other cashflows from financing activities | 17.13M | 23.99M | 108.12M | 434.50M | 173.56M |
| Change to netincome | - | - | - | 28.03M | 17.71M |
| Capital expenditures | 116.44M | 133.72M | 107.38M | 89.45M | 56.81M |
| Change receivables | - | - | - | 17.84M | -53.77M |
| Cash flows other operating | - | - | - | -0.13M | -21.50M |
| Cash and cash equivalents changes | - | - | - | 15.88M | 4.49M |
| Change in working capital | -21.32M | 13.63M | -6.48M | 3.72M | -4.67M |
| Stock based compensation | 6.82M | 7.85M | 8.31M | 10.28M | 11.30M |
| Other non cash items | 0.52M | 2.59M | -2.57M | 2.14M | 2.39M |
| Free cash flow | 6.42M | 1.69M | 10.17M | 184.15M | 162.04M |
Sector: Basic Materials Industry: Chemicals
|
Stock Name
|
Change
(USD) |
Price
(USD) |
Trailing
PE (x) |
Forward
PE (x) |
Price Sales
TTM (x) |
Price to Book Value (x)
|
Enterprise Value
to Revenue (x) |
Enterprise Value
to EBITDA (x) |
|---|---|---|---|---|---|---|---|---|
| ASIX AdvanSix Inc |
0.33 2.20% |
15.36 | 12.36 | - | 0.39 | 0.73 | 0.63 | 6.72 |
| SHECF Shin-Etsu Chemical Co. Ltd |
- -% |
38.02 | 23.22 | 18.73 | 0.03 | 2.38 | 3.50 | 9.45 |
| SHECY Shin-Etsu Chemical Co Ltd ADR |
-0.37 1.94% |
18.67 | 22.65 | 18.25 | 0.03 | 2.32 | 3.46 | 9.34 |
| BFFAF BASF SE NA O.N. |
- -% |
57.33 | 33.31 | 25.58 | 0.93 | 1.43 | 1.13 | 8.85 |
| BASFY BASF SE ADR |
-0.03 0.20% |
14.96 | 33.15 | 25.25 | 0.93 | 1.41 | 1.13 | 8.85 |
AdvanSix Inc., integrated chemistry company, engages in the manufacture and sale of polymer resins in the United States and internationally. The company offers Nylon 6, a polymer resin, which is a synthetic material used to produce fibers, filaments, engineered plastics, and films. It also provides caprolactam to manufacture polymer resins; ammonium sulfate fertilizers to distributors, farm cooperatives, and retailers; and acetone that are used in the production of adhesives, paints, coatings, solvents, herbicides, and resins. In addition, the company offers intermediate chemicals, including phenol, alpha-methylstyrene, cyclohexanone, oximes, cyclohexanol, and alkyl and specialty amines; and cyclohexanol, sulfuric acid, ammonia, and carbon dioxide, as well as automotive components, water treatment, and pharmaceutical intermediates. It offers its products under the Aegis, Sulf-N, Nadone, Naxol, and EZ-Blox under brand names. The company sells its products directly and through distributors. AdvanSix Inc. was incorporated in 2016 and is headquartered in Parsippany, New Jersey.
| Name | Title | Year Born |
|---|---|---|
| Ms. Erin N. Kane | CEO, Pres & Director | 1977 |
| Mr. Michael Preston | CFO & Sr. VP | 1972 |
| Mr. Achilles B. Kintiroglou | Sr. VP, Gen. Counsel & Corp. Sec. | 1979 |
| Ms. Kelly Slieter | Sr. VP & Chief HR Officer | 1975 |
| Adam Kressel | Director of Investor Relations | NA |
| Mr. Christopher Gramm | VP & Controller | 1970 |
| Ms. Erin N. Kane | CEO, President & Director | 1977 |
| Mr. Achilles B. Kintiroglou | Senior VP, General Counsel & Corporate Secretary | 1979 |
| Ms. Kelly J. Slieter | Senior VP & Chief Human Resources Officer | 1975 |
| Mr. Michael Preston C.F.A. | Executive Officer | 1972 |
Disclaimer - (*)This information, including any data, is sourced from Unicorn Data Services SAS, trading as EOD Historical Data (“EODHD”) on an ‘as is’ basis, using their API. We cannot guarantee the completeness or validity of the information and data provided on this page, as well as via the API. In some cases, the data may include analyst ratings or recommendations sourced through the EODHD API, which are intended solely for general information purposes.
This information does not consider your personal objectives, financial situation, or needs. Kalkine is not liable for any errors or omissions in the information provided or for any actions taken in reliance on it. You should seek advice from a financial adviser, stockbroker or other professional adviser (including taxation and legal advice) as necessary before acting on this information.
Download a free report with stock ideas and industry insights for general information.
Download Free Report Now →
Basic Materials
-1.82%
Communication Services
-0.22%
Consumer Cyclical
-0.13%
Consumer Defensive
+0.32%
Energy
+0.15%
Financial Services
-0.85%
Financials
+2.34%
Healthcare
-1.28%
Industrials
-0.96%
Real Estate
-0.38%
Technology
-2.73%
Utilities
-0.31%
Note: Daily price change (%) by sector excluding stocks with +/-90% daily price change. Companies above $500 million market capitalization are considered.
Portfolio
Watchlist
Please wait processing your request...